INTRODUCTION Celiac disease (CD) is a permanent intolerance to gluten that occurs in genetically predisposed individuals and leads to small intestinal mucosa damage. According to ESPGHAN guidelines from 2012, CD can be diagnosed in a patient with characteristic clinical symptoms, in whom, anti-tissue transglutaminase antibodies (> 10 times the upper limit) are found, endomysial antibodies (EMA)...

As an autoimmune disease, type 1 diabetes mellitus (DM) can be associated with other autoimmune disorders. The aim of this study was to detect subclinically associated autoimmune thyroid disease, coeliac disease, and Addison's disease. The presence of autoantibodies was evaluated with special regard to the control of diabetes and to the clinical status of the patient. Fifty-one type 1 diabetic ...

INTRODUCTION Autoantibodies are often produced during infection with chronic hepatitis C virus (HCV), but it remains controversial whether they influence the biochemical profile and histological features of this disease. Therefore, this current study sought to describe these autoantibodies and evaluate their impact on the clinical and histological presentation of hepatitis C. METHODS This cro...

Eyelid myoclonia with absences (EMA), also known as Jeavons syndrome (JS) is a childhood onset epileptic manifestations involving clinical triad of absence seizures eyelid (EM), photosensitivity (PS), and or electroencephalogram (EEG) paroxysms induced by eye closure. Although genetic contribution to this likely some alterations have been defined in several cases, the genes responsible for not ...

Autophagy is a cellular homeostatic response that involves degradation of self-components by the double-membraned autophagosome. The biogenesis of autophagosomes has been well described, but the ensuing processes after autophagosome formation are not clear. In our recent study, we proposed a model in which the Golgi complex contributes to the growth of autophagic structures, and that the Drosop...

In this paper, we propose EMA, a novel scheme that guarantees the authenticity of a mobile node (MN) and a relay node (RN) in a multi-hop-enabled Proxy Mobile IP (PMIP) network. EMA works in conjunction with a proposed scheme for key establishment, based on symmetric polynomials, to generate a shared secret key between MN and RN. This scheme achieves lower revocation overhead than that achieved...

The main objective of emergency medical assistance (EMA) services is to attend patients with sudden diseases at any possible location within an area of influence. This usually consists in providing “in situ” assistance and, if necessary, the transport of the patient to a medical centre. The potential of such systems to reduce mortality is directly related to the travel times of ambulances to em...